Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-07

Clinical Trial Update: A Study to Assess Jia Wei Yang He Formula as a Plus Therapy in the Treatment of Persistent Asthma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating Jia Wei Yang He Formula as an add-on therapy for persistent asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jia Wei Yang He Formula

Snippet

Sponsor: Shanghai University of Traditional Chinese Medicine | Conditions: Bronchial Asthma | Phase 2 | Status: UNKNOWN